TipRanks
Quince Therapeutics price target raised to $5 from $4 at D. Boral Capital
📈
AI Sentiment
Highly Positive
8/10
Quince Therapeutics Inc. News
Latest updates and market news for QNCX
2 news
Dec 15 - Dec 21, 2025
Page 1
Business Wire
Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia
📈
AI Sentiment
Highly Positive
8/10
Share this news page